Barosi, G

Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia. [electronic resource] - British journal of haematology Jul 2001 - 78-83 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0007-1048

10.1046/j.1365-2141.2001.02918.x doi


Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors--adverse effects
Fatigue--chemically induced
Feasibility Studies
Female
Follow-Up Studies
Humans
Leukocyte Count
Male
Middle Aged
Neutropenia--chemically induced
Platelet Count
Primary Myelofibrosis--complications
Thalidomide--adverse effects